Liraglutide studies: 1,219 papers with results
Page 17 of 25
- Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes.
Derington CG · JAMA network open · 2025
Observational study · 37 results
- Real-world safety comparison of liraglutide and semaglutide in weight management: Insights from European pharmacovigilance data.
Ruggiero R · European journal of pharmacology · 2025
Observational study · 25 results
- Muscle atrophy associated with glucagon-like Peptide-1 receptor agonists: A population-based observational study.
Kwan ATH · Clinical nutrition (Edinburgh, Scotland) · 2026
Observational study · 3 results
- Comparative pharmacovigilance analysis of suicidality-related adverse events among GLP-1 and non-GLP-1 anti-obesity drugs in the FDA Adverse Event Reporting System.
Seijas-Amigo J · International journal of clinical pharmacy · 2026
Observational study · 8 results
- Risk of Dementia after initiation of GLP-1 RA versus long-acting insulin in patients with type 2 Diabetes mellitus.
Lin CH · The journal of prevention of Alzheimer's disease · 2026
Observational study · 10 results
- Cohort Study: Risk of Gallstones and Biliary Complications With Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes.
Eldesouki MH · United European gastroenterology journal · 2026
Observational study · 24 results
- GLP-1 receptor agonists, SGLT-2 inhibitors, and their combination: effects on carotid atherosclerosis regression, oxidative stress, and amyloid-β1-40 in diabetes.
Ikonomidis I · American journal of physiology. Heart and circulatory physiology · 2026
Observational study · 12 results
- Improvement in Helicobacter pylori Eradication Among Adults Receiving Semaglutide: A Population-Based Propensity-Score-Adjusted Analysis.
Ness A · Helicobacter · 2025
Observational study · 7 results
- Use of liraglutide after bariatric surgery: a 36-month follow-up in a real-world setting in Chile.
Farías MM · Archives of endocrinology and metabolism · 2024
Observational study · 5 results
- Comparative analysis of serious adverse effects of antidiabetic drugs and complications associated with type II diabetes mellitus.
Barakat HE · BMC pharmacology & toxicology · 2026
Observational study · 1 result
- Assessing the Association Between GLP-1 Receptor Agonists and Diabetic Foot Complications Using Real-World Pharmacovigilance Database and Mendelian Randomization.
Zhang T · The international journal of lower extremity wounds · 2026
Observational study · 9 results
- Glucagon-like peptide-1 receptor agonist-associated injection site and dermatologic reactions.
Elgindi D · Clinics in dermatology · 2026
Observational study · 8 results
- Real-World Comparative Weight Loss of GLP-1 Receptor Agonists in the All of Us Research Program: A Retrospective Cohort Study.
Hwang I · Drug design, development and therapy · 2026
Observational study · 9 results
- Optic Ischaemic Neuropathy in Incretin-Based Therapy: A Comparative Analysis of Real-World Safety Data.
Kakkar AK · Diabetes, obesity & metabolism · 2026
Observational study · 5 results
- Health Care Costs and Use of Patients Prescribed Four Different Obesity Medications.
Lewis KH · Obesity (Silver Spring, Md.) · 2026
Observational study · 3 results
- Association between incretin-related drugs and fractures in patients treated with pioglitazone: A pharmacovigilance study using the FDA Adverse Event Reporting System.
Ohyama K · International journal of clinical pharmacology and therapeutics · 2026
Observational study · 3 results
- The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in type 2 diabetes patients (TROPHIES): resource use and costs of treatment in clinical practice in France, Germany, and Italy.
Barrett A · Journal of medical economics · 2024
Observational study · 3 results
- Case Report: Off-Label Liraglutide Use in Children With Wolfram Syndrome Type 1: Extensive Characterization of Four Patients.
Frontino G · Frontiers in pediatrics · 2021
Case report or series · 7 results
- Liraglutide in whole-pancreas transplant patients with impaired glucose homoeostasis: A case series.
Cariou B · Diabetes & metabolism · 2015
Case report or series · 5 results
- GLP-1 Agonists in Plastic Surgery: Impact on Aesthetic Outcomes-Two Case Reports.
Taraschi F · Aesthetic plastic surgery · 2025
Case report or series · 4 results
- Congenital Glucagon-like Peptide-1 Deficiency in the Pathogenesis of Protracted Diarrhea in Mitchell-Riley Syndrome.
Nóbrega S · The Journal of clinical endocrinology and metabolism · 2021
Case report or series · 1 result
- Liraglutide with Lifestyle Intervention in Adolescents with Overweight/Obesity, Nonalcoholic Fatty Liver Disease, and Type II Diabetes Mellitus.
Kohut T · JPGN reports · 2021
Case report or series · 3 results
- GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report.
Iepsen EW · Cell reports. Medicine · 2020
Case report or series · 5 results
- Maturity-Onset diabetes of the young type 5 treated with the glucagon-like peptide-1 receptor agonist: A case report.
Terakawa A · Medicine · 2020
Case report or series · 3 results
- A Diabetic Patient Complicated With Pancreatic Cancer After Using Liraglutide: A Case Report.
Wu S · Frontiers in endocrinology · 2020
Case report or series · 2 results
- Liraglutide-Induced Pancreatitis: A Case Report and Literature Review.
Javed H · Cureus · 2023
Case report or series · 2 results
- Efficacy of sodium-glucose cotransporter 2 inhibitor with glucagon-like peptide-1 receptor agonist for the glycemic control of a patient with Prader-Willi syndrome: a case report.
Sano H · Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2020
Case report or series · 4 results
- Glucagon-like peptide-1 analog therapy in rare genetic diseases: monogenic obesity, monogenic diabetes, and spinal muscular atrophy.
Zaitoon H · Acta diabetologica · 2023
Case report or series · 9 results
- Suspected Gastroparesis With Concurrent Gastroesophageal Reflux Disease Induced by Low-Dose Liraglutide.
Ishihara Y · Cureus · 2022
Case report or series · 3 results
- Liraglutide Overdose-Induced Acute Pancreatitis.
AlSaadoun AR · Cureus · 2022
Case report or series · 1 result
- Liraglutide-Induced Hemorrhagic Pancreatitis in a Nondiabetic Patient.
Dolan RD · ACG case reports journal · 2020
Case report or series · 1 result
- Liraglutide-associated depression in a patient with type 2 diabetes: A case report and discussion.
He Y · Medicine · 2024
Case report or series · 2 results
- Different Effects of Once-weekly and Once-daily Administered GLP-1RA Semaglutide and Liraglutide on Bile Acid Diarrhea.
Kårhus ML · JCEM case reports · 2023
Case report or series · 2 results
- Effects of Semaglutide on Glycemic Control and Weight Loss in a Patient with Prader-Willi Syndrome: A Case Report.
Sani E · Endocrine, metabolic & immune disorders drug targets · 2022
Case report or series · 5 results
- Gastroparesis With the Initiation of Liraglutide: A Case Report.
Almustanyir S · Cureus · 2020
Case report or series · 1 result
- Liraglutide overdose: A case report and an updated review.
Nafisah SB · Turkish journal of emergency medicine · 2020
Case report or series · 2 results
- Exposure to High-Dose Liraglutide in a Pregnant Woman With Obesity.
Abushanab D · O&G open · 2025
Case report or series · 3 results
- Successful treatment of hyperglycemia with liraglutide in a hospitalized 27-year-old patient with schizophrenia: A case report.
Zhang L · World journal of clinical cases · 2022
Case report or series · 3 results
- Delayed Type Hypersensitivity Reaction Induced By Liraglutide With Tolerance to Semaglutide.
Moreno-Borque R · JCEM case reports · 2024
Case report or series · 2 results
- Lifestyle Interventions in a Patient Identified as Super-Super Obese With a Body Mass Index of 90.5.
Al Ghareeb G · Journal of medical cases · 2024
Case report or series · 1 result
- Liraglutide and Liver Injury: Rare Case Report with Literature Review.
Salehi AM · Endocrine, metabolic & immune disorders drug targets · 2024
Case report or series · 2 results
- A Liraglutide Injection Superimposing a Starvation Acidosis: a Case Report.
Alghamdi M · Medical archives (Sarajevo, Bosnia and Herzegovina) · 2022
Case report or series · 1 result
- An Exceedingly Rare Case of Liraglutide-Induced Liver Injury.
Parvataneni S · Case reports in gastrointestinal medicine · 2021
Case report or series · 2 results
- Hypocalcemia secondary to hypomagnesemia in a patient on liraglutide.
Habnouny JEL · Annals of medicine and surgery (2012) · 2020
Case report or series · 2 results
- Diabetes of Unclear Type in an Adolescent Boy With Multiple Islet-cell Autoantibody Positivity Successfully Managed With Glucagon-like Peptide-1 Receptor Agonist Alone: A Case Report.
Ginnard OZB · Canadian journal of diabetes · 2023
Case report or series · 1 result
- The Liraglutide-Induced Pemphigus Vulgaris: A First Case Report Highlighting Autoimmune Risks of GLP-1 Receptor Agonists.
Cai S · Endocrine, metabolic & immune disorders drug targets · 2026
Case report or series · 4 results
- Tirzepatide-Induced Liver Injury: A Rare Complication.
Spaeth LD · AACE endocrinology and diabetes · 2026
Case report or series · 8 results
- Liraglutide use in pediatric type 2 familial partial lipodystrophy caused by LMNA mutation: a case report.
Li Y · BMC pediatrics · 2025
Case report or series · 1 result
- Acute Kidney and Liver Injury Associated With Low-Dose Liraglutide in an Obese Adolescent Patient.
Komargodski R · Pediatrics · 2024
Case report or series · 6 results
- Scientific report: a case of acute pancreatitis due to liraglutide.
Quesada-Vázquez N · Revista espanola de enfermedades digestivas · 2019
Case report or series · 1 result